Close

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more

In-licensing requirements

About Shire

  • Shire Pharmaceuticals is a rapidly growing company whose purpose is to enable people with life-altering conditions to lead better lives.
  • Shire’s development focus is in central nervous system disorders, gastro-intestinal, regenerative medicine, human genetic therapies and orphan diseases
  • Shire has completed nine mergers and acquisitions in eleven years
  • In-licensing and product acquisitions are a priority at Shire

Why partner with Shire?

  • Shire has an impressive and balanced portfolio of products, many of which derive from successful external collaborations
  • Shire has a sales and marketing capability in major markets throughout the world
  • Partners benefit from Shire’s excellent track record of product development and commercialisation
  • Shire retains a flexible and creative approach to collaborations
  • Shire manages its collaborations in a rapid and responsible manner through a dedicated Alliance Management group

What are Shire’s in-licensing interests?

  • Depending upon the indication, collaborations may be formed at various stages of the development process
  • Shire welcomes approaches from potential collaborators with products that match Shire’s strategic focus areas

Did you know...

We have developed a
version of this web site
that is suitable for your
portable device
.

Our global reach

Our products are marketed in over 50 countries worldwide, and we now have offices in 29 countries. View our interactive map, and learn more
about our global reach.

Our locations